Apply for a Mid-Career Bridge Grant!


Apply for a Mid-Career Bridge Grant!

This year, the MRF is proud to introduce a new research grant category supporting mid-career melanoma researchers. Application deadlines are quickly approaching, learn more about the Mid-Career Bridge Grant and apply by August 15!

Ocular Melanoma

Eyes on a Cure: Ocular Melanoma Patient Symposium



Ocular Melanoma

Eyes on a Cure: Ocular Melanoma Patient Symposium

After more than two years, the CURE OM Patient & Caregiver Symposium is back! Learn the latest news in OM research and treatment development either virtually or in person at Sidney Kimmel Cancer Center in Philadelphia, PA on Friday, August 26!

Miles for Melanoma

Join Miles for Melanoma!

Miles for Melanoma

Join Miles for Melanoma!

Join melanoma patients, survivors, caregivers and supporters in cities across the US to walk, run and raise life-saving funds for melanoma research. Click here to find a 5k run/walk near you and register today!




What is TIL Therapy?

NEW: Check out the latest animated video in the MRF Education Institute to learn more about tumor infiltrating lymphocyte (TIL) therapy, how it is used to treat melanoma and which patients may benefit from this form of treatment.




Attend a Gala

Celebrate courageous members of the melanoma community and health care heroes at the Denver and New York City Galas! Click here to purchase your tickets today!


Apply Today for Federal Research Funding



Apply Today for Federal Research Funding

Multiple research grant opportunities are now available from the Department of Defense Melanoma Research Program. Learn more and apply by September 14, 2022!

The MRF’s mission is to eradicate melanoma by accelerating medical RESEARCH while EDUCATING to and ADVOCATING for the melanoma community.

Melanoma is the deadliest form of skin cancer.

Melanoma claims the lives of over 7,000 Americans every year.

Melanoma is the leading cause of cancer death in young women ages 25 – 30 and the second leading cause of cancer death in women ages 30-35.

9 out of 10 cases are considered to be preventable.

Funding Melanoma Research

Funding from The MRF has resulted in:

clinical trials

25 Clinical trials


109 Grants with new collaborations


236 Publications


484 Presentations

Recent Funded Research Recipients

Melanoma Risks and Risk Prediction in Patients with Actinic Keratosis
Therapeutic Resistance to CDK4/6 inhibitors in BRAF-mutant Melanoma
Targeted intervention of melanoma by reprogramming the stromal translatome
Control of Anti-Tumor Response by the Modulation of Neurotransmitter-Expressing Immune Cells

Latest News

ALEXANDRIA, Va. - Conquer Cancer®, the ASCO Foundation, and the Melanoma Research Foundation (MRF) are pleased to announce Leslie K.
$20,000 Raised by 3 Reasons to Race Event in May at Birch Run Speedway Benefits Largest Independent Organization Devoted to
Majic WMJI Morning Show Host Lends Support to Eradicate Melanoma at Upcoming 5k Race Cleveland, OH (July 28, 2022) -
WASHINGTON, DC (June 23, 2022) – The Melanoma Research Foundation’s (MRF) CURE OM initiative, dedicated to increasing awareness, education and

Optimize Your Treatment

Although the MRF cannot recommend a specific doctor, clinic or clinical trial, the Melanoma Treatment Center Finder and Clinical Trial Finder will help you find an experienced melanoma treatment team, as well as give you the opportunity to explore clinical trials. Did you know that clinical trials are often viewed as the best treatment option for Stage II, III and IV melanoma patients?

Please remember to use this information as a starting point in your search for a healthcare team that best meets your needs. All information regarding your treatment should be discussed with your healthcare professional.


Shop to Support MRF.

Grab some merch to support our mission to eradicate melanoma by accelerating medical research while educating to and advocating for the melanoma community.




The MRF is committed to providing the most up-to-date education and support resources for melanoma patients and their loved ones.